Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.

BACKGROUND Depressive symptoms are common among patients with chronic obstructive pulmonary disease (COPD), but depression's impact on COPD outcomes has not been fully investigated. We evaluated the impact of comorbid depression on mortality, hospital readmission, smoking behavior, respiratory symptom burden, and physical and social functioning in patients with COPD. METHODS In this prospective cohort study, 376 consecutive patients with COPD hospitalized for acute exacerbation were followed up for 1 year. The independent associations of baseline comorbid depression (designated as a Hospital Anxiety and Depression Scale score of > or =8) with mortality, hospital readmission, length of stay, persistent smoking, and quality of life (determined by responses to the St George Respiratory Questionnaire) were evaluated after adjusting for potential confounders. RESULTS The prevalence of depression at admission was 44.4%. The median follow-up duration was 369 days, during which 57 patients (15.2%) died, and 202 (53.7%) were readmitted at least once. Multivariate analyses showed that depression was significantly associated with mortality (hazard ratio, 1.93; 95% confidence interval, 1.04-3.58), longer index stay (mean, 1.1 more days; P = .02) and total stay (mean, 3.0 more days; P = .047), persistent smoking at 6 months (odds ratio, 2.30; 95% confidence interval, 1.17-4.52), and 12% to 37% worse symptoms, activities, and impact subscale scores and total score on the St George Respiratory Questionnaire at the index hospitalization and 1 year later, even after controlling for chronicity and severity of COPD, comorbidities, and behavioral, psychosocial, and socioeconomic variables. CONCLUSIONS Comorbid depressive symptoms in patients with COPD are associated with poorer survival, longer hospitalization stay, persistent smoking, increased symptom burden, and poorer physical and social functioning. Interventions that reduce depressive symptoms may potentially affect COPD outcomes.

[1]  Pedro Almagro,et al.  Risk Factors for Hospital Readmission in Patients with Chronic Obstructive Pulmonary Disease , 2006, Respiration.

[2]  T. Gislason,et al.  Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. , 2006, Respiratory medicine.

[3]  E. Wouters,et al.  Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. , 2005, Archives of internal medicine.

[4]  A. Jemal,et al.  Trends in the leading causes of death in the United States, 1970-2002. , 2005, JAMA.

[5]  T. Gislason,et al.  Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression , 2005, European Respiratory Journal.

[6]  A. Yohannes,et al.  Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. , 2005, Age and ageing.

[7]  C. Pisinger,et al.  Depression and chronic obstructive pulmonary disease (COPD). Impact on survival , 2005, Acta psychiatrica Scandinavica.

[8]  R. Godoy,et al.  A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. , 2003, Archives of physical medicine and rehabilitation.

[9]  D. V. de Godoy,et al.  A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. , 2003, Archives of physical medicine and rehabilitation.

[10]  E. Clini,et al.  Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. , 2003, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[11]  M. Chan-yeung,et al.  Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. , 2002, Chest.

[12]  Christer Janson,et al.  Anxiety and Depression are Related to the Outcome of Emergency Treatment in Patients with Obstructive Pulmonary Disease. , 2002, Chest.

[13]  Jordi Alonso,et al.  Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[14]  Shin-Ping Tu,et al.  Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. , 2002, Chest.

[15]  Gary Rodin,et al.  Depression in medical patients , 2002, BMJ : British Medical Journal.

[16]  S. Quintana,et al.  Mortality after hospitalization for COPD. , 2002, Chest.

[17]  D. Mannino.  COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.

[18]  E Monsó,et al.  Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. , 2001, American journal of respiratory and critical care medicine.

[19]  A. Yohannes,et al.  A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease † , 2001, International journal of geriatric psychiatry.

[20]  W. Katon,et al.  The association between depressive symptoms and health status in patients with chronic pulmonary disease. , 2001, General hospital psychiatry.

[21]  A. Yohannes,et al.  Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire , 2000, International journal of geriatric psychiatry.

[22]  W. Katon,et al.  Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. , 2000, Archives of internal medicine.

[23]  R. White,et al.  Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. , 1999, Journal of cardiopulmonary rehabilitation.

[24]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[25]  M. Lye,et al.  Placebo‐controlled treatment trial of depression in elderly physically ill patients , 1997, International journal of geriatric psychiatry.

[26]  J. G. Douglas,et al.  Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.

[27]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[28]  A. Ries,et al.  Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995, Annals of Internal Medicine.

[29]  C. Lam,et al.  Can the Hospital Anxiety and Depression (HAD) Scale be used on Chinese elderly in general practice? , 1995, Family practice.

[30]  K. P. Hui,et al.  Ventilatory function measured with the Micro Spirometer: performance evaluation and reference values. , 1995, Annals of the Academy of Medicine, Singapore.

[31]  N. Frasure-smith,et al.  Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.

[32]  K. Wells,et al.  Course of depression in patients with hypertension, myocardial infarction, or insulin-dependent diabetes. , 1993, The American journal of psychiatry.

[33]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[34]  S. Borson,et al.  Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. , 1992, Psychosomatics.

[35]  W. Katon,et al.  Depression and chronic medical illness. , 1990, The Journal of clinical psychiatry.

[36]  A. Rifkin,et al.  The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. , 1990, The American journal of psychiatry.

[37]  Gardner Rm,et al.  Standardization of spirometry--1987 ATS update (American Thoracic Society) , 1988 .

[38]  J. Hankinson,et al.  Standardization of spirometry--1987 ATS update (American Thoracic Society) , 1988, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[39]  P. Yellowlees,et al.  Psychiatric morbidity in patients with chronic airflow obstruction , 1987, The Medical journal of Australia.

[40]  R. Light,et al.  Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. , 1985, Chest.

[41]  G. Prigatano,et al.  Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. , 1984, Archives of internal medicine.

[42]  R. Snaith,et al.  The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.

[43]  I. Grant,et al.  Life quality of patients with chronic obstructive pulmonary disease. , 1982, Archives of internal medicine.

[44]  C. E. Kossman.  NOMENCLATURE AND CRITERIA FOR THE DIAGNOSIS OF CARDIOVASCULAR DISEASES. , 1964, Circulation.